SLS
Sellas Life Sciences Group Inc
11.40$
-1.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | – | – | – | +399,900.0% | -86.8% | -100.0% | – | – | |
| – | -74.7% | -99.2% | -100.0% | – | – | – | -46.9% | -50.0% | -100.0% | – | – | |
| – | -104.5% | – | – | – | – | – | +389,373.7% | -87.8% | -100.0% | – | – | |
| – | -16.7% | -15.9% | -69.5% | +201.9% | -44.8% | -8.3% | +130.3% | +41.6% | -20.7% | -20.5% | -16.1% | |
| – | -66.2% | +13.2% | +25.7% | -15.4% | -22.3% | -3.3% | +17.9% | +11.1% | +10.2% | -10.4% | -1.3% | |
| – | -43.7% | -5.9% | -33.6% | +49.3% | -36.6% | -194.2% | – | +31.1% | -11.6% | -16.8% | -10.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -31.5% | +361.6% | -86.8% | -42.4% | -55.6% | +230.5% | +1,017.4% | -85.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -33.4% | +4.1% | -644.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +3,870.7% | -169.1% | – | – | +19.5% | -4,350.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.